Unknown

Dataset Information

0

Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2.


ABSTRACT: Hyperactivation of the Ras/ERK pathway contributes to breast cancer initiation and progression, and recent evidence suggests aberrant signaling of miRNAs that regulate the Ras/ERK pathway play important roles during carcinogenesis and cancer progression. In this study, we demonstrate that miR-550a-3p expression is negatively correlated with levels of ERK1 and ERK2, two pivotal effectors in the Ras/ERK pathway. MiR-550a-3p gradually decreased during breast cancer initiation and progression and this reduction was a prognostic indicator of poorer overall survival (OS) and disease-free survival (DFS) among breast cancer patients. Our mechanistic studies demonstrated that miR-550a-3p exerts its tumor-suppressor role by directly repressing ERK1 and ERK2 protein expression, thereby suppressing the oncogenic ERK/RSK cascades, which reduced breast cancer cell viability, survival, migration, invasion, tumorigenesis, and metastasis. The inhibitory effects of miR-550a-3p were rescued by ectopic expression of ERK1 and/or ERK2. The novel connection between miR-550a-3p and ERK defines a new diagnostic and prognostic role for miR-550a-3p and highlights ERK inhibition as a candidate therapeutic target for breast cancers exhibiting hyperactivated Ras/ERK signaling.

SUBMITTER: Ho JY 

PROVIDER: S-EPMC5288226 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2.

Ho Jar-Yi JY   Hsu Ren-Jun RJ   Wu Chih-Hsi CH   Liao Guo-Shiou GS   Gao Hong-Wei HW   Wang Tong-Hong TH   Yu Cheng-Ping CP  

Oncotarget 20160801 33


Hyperactivation of the Ras/ERK pathway contributes to breast cancer initiation and progression, and recent evidence suggests aberrant signaling of miRNAs that regulate the Ras/ERK pathway play important roles during carcinogenesis and cancer progression. In this study, we demonstrate that miR-550a-3p expression is negatively correlated with levels of ERK1 and ERK2, two pivotal effectors in the Ras/ERK pathway. MiR-550a-3p gradually decreased during breast cancer initiation and progression and th  ...[more]

Similar Datasets

| S-EPMC5861059 | biostudies-literature
2021-01-23 | GSE165341 | GEO
| S-EPMC8632778 | biostudies-literature
| S-EPMC4853935 | biostudies-literature
| 2260465 | ecrin-mdr-crc
| S-EPMC9682529 | biostudies-literature
| S-EPMC6257964 | biostudies-literature
| S-EPMC7407124 | biostudies-literature
| S-EPMC6613506 | biostudies-literature
| S-EPMC9951500 | biostudies-literature